Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Publication year range
1.
PLoS Pathog ; 13(9): e1006603, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28945820

ABSTRACT

Various bacterial toxins circumvent host defenses through overproduction of cAMP. In a previous study, we showed that edema factor (EF), an adenylate cyclase from Bacillus anthracis, disrupts endocytic recycling mediated by the small GTPase Rab11. As a result, cargo proteins such as cadherins fail to reach inter-cellular junctions. In the present study, we provide further mechanistic dissection of Rab11 inhibition by EF using a combination of Drosophila and mammalian systems. EF blocks Rab11 trafficking after the GTP-loading step, preventing a constitutively active form of Rab11 from delivering cargo vesicles to the plasma membrane. Both of the primary cAMP effector pathways -PKA and Epac/Rap1- contribute to inhibition of Rab11-mediated trafficking, but act at distinct steps of the delivery process. PKA acts early, preventing Rab11 from associating with its effectors Rip11 and Sec15. In contrast, Epac functions subsequently via the small GTPase Rap1 to block fusion of recycling endosomes with the plasma membrane, and appears to be the primary effector of EF toxicity in this process. Similarly, experiments conducted in mammalian systems reveal that Epac, but not PKA, mediates the activity of EF both in cell culture and in vivo. The small GTPase Arf6, which initiates endocytic retrieval of cell adhesion components, also contributes to junctional homeostasis by counteracting Rab11-dependent delivery of cargo proteins at sites of cell-cell contact. These studies have potentially significant practical implications, since chemical inhibition of either Arf6 or Epac blocks the effect of EF in cell culture and in vivo, opening new potential therapeutic avenues for treating symptoms caused by cAMP-inducing toxins or related barrier-disrupting pathologies.


Subject(s)
Antigens, Bacterial/pharmacology , Bacterial Toxins/pharmacology , Edema/metabolism , Endosomes/drug effects , Intercellular Junctions/drug effects , ADP-Ribosylation Factor 6 , ADP-Ribosylation Factors/metabolism , Adenylyl Cyclases/metabolism , Animals , Cadherins/metabolism , Cell Line , Endosomes/metabolism , Intercellular Junctions/metabolism , Protein Transport/drug effects , rab GTP-Binding Proteins/metabolism
2.
Cell Host Microbe ; 14(3): 294-305, 2013 Sep 11.
Article in English | MEDLINE | ID: mdl-24034615

ABSTRACT

Cholera toxin (CT), a virulence factor elaborated by Vibrio cholerae, is sufficient to induce the severe diarrhea characteristic of cholera. The enzymatic moiety of CT (CtxA) increases cAMP synthesis in intestinal epithelial cells, leading to chloride ion (Cl(-)) efflux through the CFTR Cl(-) channel. To preserve electroneutrality and osmotic balance, sodium ions and water also flow into the intestinal lumen via a paracellular route. We find that CtxA-driven cAMP increase also inhibits Rab11/exocyst-mediated trafficking of host proteins including E-cadherin and Notch signaling components to cell-cell junctions in Drosophila, human intestinal epithelial cells, and ligated mouse ileal loops, thereby disrupting barrier function. Additionally, CtxA induces junctional damage, weight loss, and dye leakage in the Drosophila gut, contributing to lethality from live V. cholerae infection, all of which can be rescued by Rab11 overexpression. These barrier-disrupting effects of CtxA may act in parallel with Cl(-) secretion to drive the pathophysiology of cholera.


Subject(s)
Cholera Toxin/metabolism , Epithelial Cells/physiology , Exosomes/drug effects , Host-Pathogen Interactions , Tight Junction Proteins/antagonists & inhibitors , Tight Junctions/physiology , Vibrio cholerae/physiology , Animals , Cell Line , Chlorine/metabolism , Cyclic AMP/metabolism , Disease Models, Animal , Drosophila , Epithelial Cells/drug effects , GTP-Binding Proteins/metabolism , Humans , Mice , Models, Biological , Sodium/metabolism , Survival Analysis , Tight Junctions/drug effects , Water/metabolism
3.
Rev. Fac. Odontol. Univ. Antioq ; 23(1): 158-173, dic. 2011. graf, tab
Article in Spanish | LILACS | ID: lil-614132

ABSTRACT

El adecuado resalte vertical de los incisivos constituye un propósito importante del tratamiento ortodóncico, en relación con el logro de objetivos estéticos (exposición dental) y la obtención de relaciones oclusales funcionales y estables a largo plazo. El desarrollo de un resalte vertical excesivo se denomina mordida profunda y es un hallazgo frecuente en ciertasdiscrepancias maxilo-mandibulares, como en las maloclusiones clase II división 2 de Angle. La corrección o camuflaje ortodóncico de la mordida profunda, puede lograrse con biomecánicas para extrusión de dientes posteriores, intrusión de dientes anteriores y labialización de incisivos. La elección de la mecánica depende de las características faciales, oclusales y funcionales particulares del paciente. El propósito de esta revisión es sintetizar los aspectos relacionados con el diagnóstico y el manejo ortodóncico delas mordidas profundas.


Adequate vertical overbite is an important purpose of the orthodontic treatment, in terms of the achievement of esthetic goals (tooth display) as well as functional, stable and long-lasting occlusal relations. Development of excessive vertical overbite is known as deep bite, and it is usually found in some maxillomandibular discrepancies, as in Angle Class II division 2 malocclusions. Deep bite orthodontic correction or camouflage can be achieved by means of biomechanics of posterior teethextrusion, anterior teeth intrusion, and/or incisors labialization. Choosing the right mechanics depends on the patient’s specific facial, occlusal and functional characteristics. The purpose of this review is to summarize the aspects associated to the diagnosisand orthodontic treatment of deep bite.


Subject(s)
Humans , Malocclusion , Orthodontic Extrusion
4.
Nature ; 467(7317): 854-8, 2010 Oct 14.
Article in English | MEDLINE | ID: mdl-20944747

ABSTRACT

Bacillus anthracis is the causative agent of anthrax in humans and other mammals. In lethal systemic anthrax, proliferating bacilli secrete large quantities of the toxins lethal factor (LF) and oedema factor (EF), leading to widespread vascular leakage and shock. Whereas host targets of LF (mitogen-activated protein-kinase kinases) and EF (cAMP-dependent processes) have been implicated in the initial phase of anthrax, less is understood about toxin action during the final stage of infection. Here we use Drosophila melanogaster to identify the Rab11/Sec15 exocyst, which acts at the last step of endocytic recycling, as a novel target of both EF and LF. EF reduces levels of apically localized Rab11 and indirectly blocks vesicle formation by its binding partner and effector Sec15 (Sec15-GFP), whereas LF acts more directly to reduce Sec15-GFP vesicles. Convergent effects of EF and LF on Rab11/Sec15 inhibit expression of and signalling by the Notch ligand Delta and reduce DE-cadherin levels at adherens junctions. In human endothelial cells, the two toxins act in a conserved fashion to block formation of Sec15 vesicles, inhibit Notch signalling, and reduce cadherin expression at adherens junctions. This coordinated disruption of the Rab11/Sec15 exocyst by anthrax toxins may contribute to toxin-dependent barrier disruption and vascular dysfunction during B. anthracis infection.


Subject(s)
Antigens, Bacterial/pharmacology , Bacillus anthracis , Bacterial Toxins/pharmacology , Endocytosis/drug effects , GTP-Binding Proteins/metabolism , rab GTP-Binding Proteins/metabolism , Adherens Junctions/metabolism , Animals , Bacillus anthracis/chemistry , Bacillus anthracis/pathogenicity , Cadherins , Cell Line , Drosophila Proteins/metabolism , Drosophila melanogaster/cytology , Drosophila melanogaster/drug effects , Drosophila melanogaster/metabolism , Drug Synergism , Endothelial Cells/drug effects , Endothelial Cells/metabolism , Female , Humans , Models, Animal , Protein Binding , Receptors, Notch/metabolism , Signal Transduction/drug effects , Transport Vesicles/drug effects , Transport Vesicles/metabolism , Vesicular Transport Proteins/metabolism
5.
Proc Natl Acad Sci U S A ; 103(9): 3244-9, 2006 Feb 28.
Article in English | MEDLINE | ID: mdl-16455799

ABSTRACT

Many bacterial toxins act on conserved components of essential host-signaling pathways. One consequence of this conservation is that genetic model organisms such as Drosophila melanogaster can be used for analyzing the mechanism of toxin action. In this study, we characterize the activities of two anthrax virulence factors, lethal factor (LF) and edema factor, in transgenic Drosophila. LF is a zinc metalloprotease that cleaves and inactivates most human mitogen-activated protein kinase (MAPK) kinases (MAPKKs). We found that LF similarly cleaves the Drosophila MAPK kinases Hemipterous (Hep) and Licorne in vitro. Consistent with these observations, expression of LF in Drosophila inhibited the Hep/c-Jun N-terminal kinase pathway during embryonic dorsal closure and the related process of adult thoracic closure. Epistasis experiments confirmed that LF acts at the level of Hep. We also found that LF inhibits Ras/MAPK signaling during wing development and that LF acts upstream of MAPK and downstream of Raf, consistent with LF acting at the level of Dsor. In addition, we found that edema factor, a potent adenylate cyclase, inhibits the hh pathway during wing development, consistent with the known role of cAMP-dependent PKA in suppressing the Hedgehog response. These results demonstrate that anthrax toxins function in Drosophila as they do in mammalian cells and open the way to using Drosophila as a multicellular host system for studying the in vivo function of diverse toxins and virulence factors.


Subject(s)
Antigens, Bacterial/metabolism , Bacterial Toxins/metabolism , Drosophila melanogaster/metabolism , Viper Venoms/metabolism , Amino Acid Sequence , Animals , Antigens, Bacterial/chemistry , Antigens, Bacterial/genetics , Bacterial Toxins/chemistry , Bacterial Toxins/genetics , Conserved Sequence , Drosophila Proteins/metabolism , Drosophila melanogaster/chemistry , Drosophila melanogaster/embryology , Drosophila melanogaster/growth & development , Gene Expression Regulation, Developmental , Hedgehog Proteins , Humans , Mitogen-Activated Protein Kinase Kinases/metabolism , Molecular Sequence Data , Phenotype , Sequence Alignment , Signal Transduction , Viper Venoms/chemistry , Viper Venoms/genetics , Wings, Animal/growth & development , Wings, Animal/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...